Nutrition app test to improve mindful eating and dietary variety in adults
Official title: Effect of a Mobile Nutrition Application on Dietary Behaviour Among Adults in a Low- and Middle-Income Country: A Randomized Controlled Trial
Run by Aga Khan University · NCT07859644 · Data updated 2026-11-12
This study tests whether a smartphone app can help adults eat more mindfully and diversify their diet in a low- and middle-income country.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Aga Khan University Academic / other |
| Locations | 1 site (Karachi, Sindh) |
| Status | Recruiting |
| Started | October 30, 2026 |
| Main results expected | March 20, 2027 |
| Study ends | March 20, 2027 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07859644 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 who own an English-speaking smartphone, can use the app, and want to improve their diet.
✕Probably not a fit
Individuals not using smartphones or unable to engage with the app may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants are adults with smartphones who will be randomly assigned to use the Kalorist app or be observed without the app for four weeks. Baseline and endline surveys will measure mindful eating, dietary diversity, self-regulation of eating, body appreciation, and related goals. The study compares changes within each group and between intervention and control groups, with a SWOT analysis collected from app users in the intervention arm. It is conducted at Aga Khan University in Karachi, with eligibility criteria focused on English-language app use and willingness to change dietary habits.
Why it matters
Potential benefit: If successful, the app could help people improve mindful eating and broaden their variety of foods.
How similar studies have gone: Previous digital nutrition tools have shown mixed but promising results in dietary behavior change; this study adds randomized data in a LMIC setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults (\>18 years old). * Owns a smartphone with internet access. * Can navigate the application in English. * Is willing to improve dietary habits. Exclusion Criteria: * Pregnant women. * Dietitians or nutrition professionals. * Current use of the same calorie/diet-tracking application. * Previous use of the same calorie/diet-tracking application. * Current participation in a structured weight-loss or dietary program. * Major medical conditions requiring a therapeutic diet.
Where it's running
-
The Aga Khan University
Karachi, Sindh, Pakistan Recruiting
Study contacts
- Principal investigator: Syed Asad Ali, MBBS, MPH, DABP, DABPID — Aga Khan University
- Study coordinator: Javeria Mansoor, MBBS
- Email: javeriaresearcher@gmail.com
- Phone: +922134864857
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.